EP1556074A4 - CASEIN DERIVED PEPTIDES AND THEIR USE IN THERAPY - Google Patents
CASEIN DERIVED PEPTIDES AND THEIR USE IN THERAPYInfo
- Publication number
- EP1556074A4 EP1556074A4 EP02758768A EP02758768A EP1556074A4 EP 1556074 A4 EP1556074 A4 EP 1556074A4 EP 02758768 A EP02758768 A EP 02758768A EP 02758768 A EP02758768 A EP 02758768A EP 1556074 A4 EP1556074 A4 EP 1556074A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- therapy
- derived peptides
- casein derived
- casein
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000005018 casein Substances 0.000 title 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title 1
- 235000021240 caseins Nutrition 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- AIDS & HIV (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Emergency Medicine (AREA)
- Marine Sciences & Fisheries (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/942,121 US20020147144A1 (en) | 2000-03-01 | 2001-08-30 | Casein derived peptides and uses thereof in therapy |
| US942121 | 2001-08-30 | ||
| PCT/IL2002/000720 WO2003018606A2 (en) | 2001-08-30 | 2002-08-29 | Casein derived peptides and uses thereof in therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1556074A2 EP1556074A2 (en) | 2005-07-27 |
| EP1556074A4 true EP1556074A4 (en) | 2008-05-07 |
Family
ID=25477603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP02758768A Withdrawn EP1556074A4 (en) | 2001-08-30 | 2002-08-29 | CASEIN DERIVED PEPTIDES AND THEIR USE IN THERAPY |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1556074A4 (cs) |
| JP (1) | JP2005511499A (cs) |
| KR (1) | KR20040078639A (cs) |
| CN (1) | CN1694719A (cs) |
| AU (1) | AU2002324323A2 (cs) |
| BR (1) | BR0212625A (cs) |
| CA (1) | CA2458924A1 (cs) |
| CZ (1) | CZ2004335A3 (cs) |
| HU (1) | HUP0500995A3 (cs) |
| IL (1) | IL160548A0 (cs) |
| MX (1) | MXPA04001890A (cs) |
| NO (1) | NO20040880L (cs) |
| PL (1) | PL375113A1 (cs) |
| WO (1) | WO2003018606A2 (cs) |
| ZA (1) | ZA200401574B (cs) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0313892D0 (en) * | 2003-06-16 | 2003-07-23 | Hannah Res Inst | Control of lactation |
| US20050192312A1 (en) * | 2004-01-30 | 2005-09-01 | Brown Dennis M. | Naphthalimide dosing by N-acetyl transferase genotyping |
| KR20070007128A (ko) * | 2004-03-01 | 2007-01-12 | 펩테라 파마슈티컬스 엘티디. | 카제인 파생 펩타이드들과 그의 치료적 사용들 |
| GB0423352D0 (en) * | 2004-10-21 | 2004-11-24 | Hannah Res Inst | "Control of mammary cell number" |
| ES2319475B1 (es) * | 2005-06-08 | 2010-02-16 | Consejo Superior Investig. Cientificas | Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion. |
| EP2030629B1 (en) * | 2006-06-09 | 2014-04-30 | Morinaga Milk Industry Co., Ltd. | Alpha-s-casein as lipid-metabolism-improving agent |
| JP2011026213A (ja) * | 2009-07-22 | 2011-02-10 | Snow Brand Milk Prod Co Ltd | 1型糖尿病抑制ペプチド |
| AU2013249522A1 (en) * | 2012-04-16 | 2014-10-30 | The Cleveland Clinic Foundation | Multivalent breast cancer vaccine |
| EP3590519A4 (en) * | 2017-03-03 | 2020-12-16 | Morinaga Milk Industry Co., Ltd. | GLP-1 SECRETAGOGUE AND COMPOSITION |
| CN107814835B (zh) * | 2017-12-01 | 2020-04-28 | 熊猫乳品集团股份有限公司 | 一种生物活性多肽avpitptlnreq及其制备方法和应用 |
| CN108017709B (zh) * | 2017-12-12 | 2020-04-10 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽kepmigvnqela及其制备方法和应用 |
| CN113952446B (zh) * | 2021-09-03 | 2023-12-05 | 河南省医药科学研究院 | 生物活性肽在抑制骨髓毒性中的应用 |
| CN120815163B (zh) * | 2025-09-16 | 2025-12-12 | 华中科技大学同济医学院附属同济医院 | 能抑制ccnb2表达的抗肿瘤药物和应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2118134A1 (cs) * | 1970-12-16 | 1972-07-28 | Assad Najjar V | |
| WO2001064234A1 (en) * | 2000-03-01 | 2001-09-07 | Chay 13 Medical Research Group N.V. | Casein derived peptides and uses thereof in therapy |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6150547A (en) * | 1997-03-21 | 2000-11-21 | Snow Brand Milk Products Co., Ltd. | Iron-casein complex hydrolyzate and process for the production thereof |
-
2002
- 2002-08-29 HU HU0500995A patent/HUP0500995A3/hu unknown
- 2002-08-29 AU AU2002324323A patent/AU2002324323A2/en not_active Abandoned
- 2002-08-29 KR KR10-2004-7002884A patent/KR20040078639A/ko not_active Withdrawn
- 2002-08-29 CZ CZ2004335A patent/CZ2004335A3/cs unknown
- 2002-08-29 CN CNA028216741A patent/CN1694719A/zh active Pending
- 2002-08-29 EP EP02758768A patent/EP1556074A4/en not_active Withdrawn
- 2002-08-29 BR BRPI0212625-7A patent/BR0212625A/pt not_active IP Right Cessation
- 2002-08-29 MX MXPA04001890A patent/MXPA04001890A/es not_active Application Discontinuation
- 2002-08-29 CA CA002458924A patent/CA2458924A1/en not_active Abandoned
- 2002-08-29 PL PL02375113A patent/PL375113A1/xx not_active Application Discontinuation
- 2002-08-29 IL IL16054802A patent/IL160548A0/xx unknown
- 2002-08-29 WO PCT/IL2002/000720 patent/WO2003018606A2/en not_active Ceased
- 2002-08-29 JP JP2003523265A patent/JP2005511499A/ja active Pending
-
2004
- 2004-02-26 ZA ZA200401574A patent/ZA200401574B/en unknown
- 2004-02-27 NO NO20040880A patent/NO20040880L/no not_active Application Discontinuation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2118134A1 (cs) * | 1970-12-16 | 1972-07-28 | Assad Najjar V | |
| WO2001064234A1 (en) * | 2000-03-01 | 2001-09-07 | Chay 13 Medical Research Group N.V. | Casein derived peptides and uses thereof in therapy |
Non-Patent Citations (1)
| Title |
|---|
| KARIYA K ET AL: "INHIBITION OF ANGIOTENSIN CONVERTING ENZYME OF RAT BRAIN WITH BRADYKININ AND ITS FRAGMENTS", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 100, no. 1, 1981, pages 31 - 36, XP008066034, ISSN: 0006-291X * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1694719A (zh) | 2005-11-09 |
| CA2458924A1 (en) | 2003-03-06 |
| KR20040078639A (ko) | 2004-09-10 |
| CZ2004335A3 (cs) | 2004-07-14 |
| EP1556074A2 (en) | 2005-07-27 |
| IL160548A0 (en) | 2004-07-25 |
| JP2005511499A (ja) | 2005-04-28 |
| MXPA04001890A (es) | 2004-06-18 |
| BR0212625A (pt) | 2007-06-19 |
| WO2003018606A9 (en) | 2004-04-08 |
| WO2003018606A3 (en) | 2005-05-06 |
| WO2003018606A2 (en) | 2003-03-06 |
| HUP0500995A3 (en) | 2008-09-29 |
| ZA200401574B (en) | 2007-02-28 |
| NO20040880L (no) | 2004-04-20 |
| HUP0500995A2 (en) | 2007-05-02 |
| AU2002324323A2 (en) | 2003-03-10 |
| PL375113A1 (en) | 2005-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0301003A3 (en) | Casein derived peptides and uses thereof in therapy | |
| IL160127A0 (en) | Tacis and br3 polypeptides and uses thereof | |
| EP1461605A4 (en) | NANOSTERIALS OF PROTEINS AND PEPTIDES | |
| HUP0500989A2 (en) | Animicrobial polypeptides and their uses | |
| AU2002346504A8 (en) | Therapeutic protein and treatments | |
| AU2002365396A8 (en) | Peptides, peptide compositions,and methods of use in binding p 185 | |
| EP1414848A4 (en) | REPLICINE PEPTIDES AND ITS USES | |
| HUP0500995A2 (en) | Casein derived peptides and uses thereof in therapy | |
| SI1462455T1 (sl) | Ser-Ser-Ser-Arg Peptid in zdravilna uporaba le-tega | |
| WO2003099841A9 (en) | Peptides and the use thereof in darkening the skin | |
| EP1419175A4 (en) | PEPTIDES OF REPLIKIN AND THEIR USE | |
| AU2002233457A1 (en) | Non-glycosylated peptides derived from the rsv g protein and use thereof in a vaccine | |
| GB9918155D0 (en) | Proteins and peptides | |
| GB0026134D0 (en) | Peptides and their use | |
| EP1080185A4 (en) | BASIC PROTEIN PEPTIDES OF MYELIN AND THE USE THEREOF. | |
| IL144225A0 (en) | ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy | |
| IL151351A0 (en) | Casein derived peptides and uses thereof in therapy | |
| HK1051501A (en) | Casein derived peptides and uses thereof in therapy | |
| GB0102447D0 (en) | Protein variants and uses thereof | |
| SG2012018057A (en) | Replikin peptides and uses thereof | |
| GB0108752D0 (en) | Peptide epitopes and uses thereof | |
| IL159495A0 (en) | Replikin peptides and uses thereof | |
| IL158109A0 (en) | Replikin peptides and uses thereof | |
| IL145527A0 (en) | Retro-inverso prosaposin-derived peptides and use thereof | |
| AU2001274923A1 (en) | Novel human thrombospondin-like proteins and polynucleotides encoding the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20040313 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20080403 |
|
| 17Q | First examination report despatched |
Effective date: 20080714 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20090127 |